Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
Jiqin Zhang, Yongxian Hu, Jiaxuan Yang, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 369-374
Open Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 439
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 324
Non-viral precision T cell receptor replacement for personalized cell therapy
Susan P. Foy, Kyle Jacoby, Daniela A. Bota, et al.
Nature (2022) Vol. 615, Iss. 7953, pp. 687-696
Open Access | Times Cited: 179
The future of engineered immune cell therapies
Darrell J. Irvine, Marcela V. Maus, David Mooney, et al.
Science (2022) Vol. 378, Iss. 6622, pp. 853-858
Open Access | Times Cited: 112
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Connor A. Tsuchida, Nadav Brandes, Raymund Bueno, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4567-4582.e20
Open Access | Times Cited: 90
CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies
Xiaomin Zhang, Hui Zhang, Huixuan Lan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 88
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 75
Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating
Mohamad Hamieh, Jorge Mansilla‐Soto, Isabelle Rivière, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 829-843
Open Access | Times Cited: 64
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 62
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 60
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 53
Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation
Xiaohui Si, Mi Shao, Xinyi Teng, et al.
Cell Metabolism (2024) Vol. 36, Iss. 1, pp. 176-192.e10
Closed Access | Times Cited: 30
Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy
Chuan Qin, Minghao Dong, Luo‐Qi Zhou, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 6
Open Access | Times Cited: 25
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 25
Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
Jiaqi Shi, Wei Wu, Dong Chen, et al.
Nature Materials (2024) Vol. 23, Iss. 6, pp. 844-853
Closed Access | Times Cited: 22
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)
Dahua Sun, Xiang Shi, Sanyan Li, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 17
Recent advances in CRISPR-Cas9-based genome insertion technologies
Xinwen Chen, Jingjing Du, Shaowei Yun, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102138-102138
Open Access | Times Cited: 17
Precise genome-editing in human diseases: mechanisms, strategies and applications
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 16
Hi-TOM 2.0: an improved platform for high-throughput mutation detection
Tingting Sun, Qing Liu, Xi Chen, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 7, pp. 1532-1534
Closed Access | Times Cited: 16
Targeted nonviral delivery of genome editors in vivo
Connor A. Tsuchida, Kevin Wasko, Jennifer Hamilton, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 15
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Chunrun Qu, Hao Zhang, Hui Cao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 45
Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer
Wei Zheng, Tianchuan Zhu, Lantian Tang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Non-viral chimeric antigen receptor (CAR) T cells going viral
Hyatt Balke‐Want, Vimal Keerthi, Amaia Cadiñanos-Garai, et al.
Immuno-Oncology Technology (2023) Vol. 18, pp. 100375-100375
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top